CC4 COST-EFFECTIVENESS ANALYSIS OF PERTUZUMAB WITH TRASTUZUMAB AND CHEMOTHERAPY COMPARED TO TRASTUZUMAB AND CHEMOTHERAPY IN THE ADJUVANT TREATMENT FOR PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER AT HIGH RISK OF RECURRENCE IN CHINA

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.048
https://www.valueinhealthjournal.com/article/S1098-3015(19)32426-X/fulltext
Title : CC4 COST-EFFECTIVENESS ANALYSIS OF PERTUZUMAB WITH TRASTUZUMAB AND CHEMOTHERAPY COMPARED TO TRASTUZUMAB AND CHEMOTHERAPY IN THE ADJUVANT TREATMENT FOR PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER AT HIGH RISK OF RECURRENCE IN CHINA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32426-X&doi=10.1016/j.jval.2019.09.048
First page :
Section Title :
Open access? : No
Section Order : 10010
Categories :
Tags :
Regions :
ViH Article Tags :